BridgeMD
New treatment option for Frozen Shoulder
Official title Is Adding Extracorporeal Shock Wave Therapy to Physiotherapy and Corticosteroid Injection Beneficial for Frozen Shoulder
ClinicalTrials.gov ID: NCT06491745
What this study is testing
- What it's testing
- Frozen shoulder, or adhesive capsulitis of the shoulder, is a common clinical problem characterized by pain, loss of both passive and active range of motion (ROM) of glenohumeral joint (GHJ), leads to functional limitation, and reduces quality of life. Primary frozen shoulder occurs without any obvious connection to any other condition, and secondary frozen shoulder is related to some medical problems, such as an injury, inflammatory, immunological, and endocrine conditions, or surgery of the shoulder.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 80
You may be able to join if
- age between 20 to 80 years old;
- shoulder pain for ≥ 1 month;
- \> 30% loss of passive range of motion (ROM) of the affected shoulder in external rotation and/or abduction, comparing with the sound side;
- pain visual analog scale on maximal passive external rotation or abduction \> 4;
- showing willing to receive ESWT, shoulder joint injection, and attend regular physical therapy programs for 8 weeks.
You likely can't join if
- severe systemic disorders including cancer, stroke, or cardiopulmonary diseases;
- uncontrolled DM;
- rotator cuff tear or calcification of the affected shoulder;
- fracture, dislocation, or arthritis of the shoulder due to rheumatic disorders;
- a history of drug allergy to local anesthetics or corticosteroids;
- pregnancy;
See the full eligibility criteria
- age between 20 to 80 years old;
- shoulder pain for ≥ 1 month;
- \> 30% loss of passive range of motion (ROM) of the affected shoulder in external rotation and/or abduction, comparing with the sound side;
- pain visual analog scale on maximal passive external rotation or abduction \> 4;
- showing willing to receive ESWT, shoulder joint injection, and attend regular physical therapy programs for 8 weeks.
- severe systemic disorders including cancer, stroke, or cardiopulmonary diseases;
- uncontrolled DM;
- rotator cuff tear or calcification of the affected shoulder;
- fracture, dislocation, or arthritis of the shoulder due to rheumatic disorders;
- a history of drug allergy to local anesthetics or corticosteroids;
- pregnancy;
- receiving ESWT, corticosteroid joint or bursa injection of the affected shoulder during the preceding three months
The study team makes the final eligibility decision.
Where it's taking place
- Taipei, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Taipei, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.